All In Biotech

Drug Trial Radar · NCT00644059

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

A Phase III, Randomized, Observer-blind, Controlled, Multi-center Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of One and Two Intramuscular Doses of Influenza Vaccine Versus Control Vaccines in Healthy Subject Aged 6 to <72 Months

Last checked: Nov 20, 2026Latest source record: Sep 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 4,902 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,902

Actual

Start

Nov 2007

Primary completion

Apr 2010

Study completion Aug 2010

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
Collaborators
Novartis Vaccines
First posted
Mar 26, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
Who can join
All sexes, from 6 months, up to 71 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy, safety and immunogenicity of one or two 0.25 mL or 0.5 mL intramuscular injections of an adjuvanted influenza vaccine compared with non-influenza and non-adjuvanted influenza control vaccines in subjects 6 to \<72 months of age.

Conditions

  • Influenza, Human

Interventions

  • Adjuvanted trivalent inactivated subunit influenza vaccineBiological

    Either two intramuscular (IM) injections of half dose or one IM injection of full dose, depending on age of subject, were administered in the deltoid muscle preferably of the non-dominant arm.

  • Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccineBiological

    For both vaccines, either two intramuscular (IM) injections of half dose or one IM injection of full dose, depending on age of subject, were administered in the deltoid muscle preferably of the non-dominant arm.

  • Meningococcal C conjugate vaccine or tick-borne encephalitis vaccineBiological

    1. Meningococcal vaccine: two IM injections 2. Tick-borne encephalitis vaccine: two IM injections

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects (Unprimed) 6 to <36 Months Age With Local and Systemic Reactions After Any Vaccination for All Seasons, Comparison of Adjuvanted Trivalent Influenza Vaccine (aTIV) and Flu Vaccine Control.Time frame: 7 days post-vaccination
  2. Percentage of Subjects (Unprimed) Aged 6 to <36 Months With Virus-Confirmed Influenza, Comparison of aTIV and Non-flu Vaccine Control (Men C/TBE Vaccine)Time frame: 3 weeks after 2nd vaccination

Locations

101 sites in 3 countries. Site status is shown where the registry gives one.

  • East Vantaa Clinic

    East Vaanta, Finland

  • Espoo Vaccine Research Clinic

    Espoo, Finland

  • Helsinki South Vaccine Research Clinic

    Helsinki, Finland

  • Helsinki East Vaccine Research Clinic

    Helsinki, Finland

  • Jarvenpaa Vaccine Research Clinic

    Jarvenpaa, Finland

  • Kokkola Vaccine Research Clinic

    Kokkola, Finland

  • Kotka Clinic

    Kotka, Finland

  • Kuopio Vaccine Clinic

    Kuopio, Finland

  • Kuopio Vaccine Research Clinic

    Kuopio, Finland

  • Lahti vaccine research Clinic

    Lahti, Finland

  • Oulu Vaccine Research Clini

    Oulu, Finland

  • Pori Vaccine Research Clinic

    Pori, Finland

  • Seinajoki Clinic

    Seinäjoki, Finland

  • Tampere Vaccine Research Clinic

    Tampere, Finland

  • Turku Clinic

    Turku, Finland

  • Vantaa West Vaccine Research Clinic

    Vantaa, Finland

  • West Vantaa Clinic

    West Vantaa, Finland

  • Praxis Dr med Thilo Heising

    Aalen Wasseralfingen, Germany

  • Praxis Dr med Ursula Hornlein

    Berlin, Germany

  • Praxis Dr med Thomas Richter

    Berlin, Germany

  • Praxis Dipl med Andreas Muhmer

    Berlin, Germany

  • Praxis Dr med Mechthild Vocks-Hauck

    Berlin, Germany

  • Praxis Dr med Klaus-Peter Falkowski

    Berlin, Germany

  • Praxis Dr med Eva Brand

    Berlin, Germany

  • Praxis Dr med Dorothea Budde

    Berlin, Germany

  • Praxis Dr. med. Cornelia Busse

    Berlin, Germany

  • Praxis Dipl. med. F. Temmler / Dipl. med. D. Wenzel

    Berlin, Germany

  • Praxis Dr med Petra van Stiphout

    Berlin, Germany

  • Praxis Dr Luise Schroeter

    Berlin, Germany

  • "Praxis Dr med Dietrich Lasius"

    Berlin, Germany

  • Praxis Dr. med. Petra Sandow

    Berlin, Germany

  • Praxis Dr Norbert Meister

    Bindlach, Germany

  • Praxis Dr med Thomas Tuschen

    Binngen Rhein, Germany

  • Praxis Dr. Elmar Dietmair

    Bobingen, Germany

  • Praxis Dr med Brigitta Becker

    Bochum, Germany

  • Praxis Karl-Heinz Blattel

    Braunfels, Germany

  • Praxis Dr. med. Roland Knecht

    Bretten, Germany

  • Praxis Dr. med. Maria R. Holtorf

    Brunsbüttel, Germany

  • Praxis Dr Klaus Helm

    Detmold, Germany

  • Praxis Joseph Zakarian

    Düsseldorf, Germany

Showing 40 of 101 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.